Trade Adaptive Biotechnologies Corporation - ADPT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.4 |
| Open | 7.18 |
| 1-Year Change | 125.08% |
| Day's Range | 7.15 - 7.57 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 7.40 | 0.16 | 2.21% | 7.24 | 7.66 | 7.08 |
| Mar 28, 2025 | 7.64 | -0.40 | -4.98% | 8.04 | 8.19 | 7.47 |
| Mar 27, 2025 | 8.15 | 0.14 | 1.75% | 8.01 | 8.50 | 7.95 |
| Mar 26, 2025 | 8.23 | -0.01 | -0.12% | 8.24 | 8.49 | 8.13 |
| Mar 25, 2025 | 8.37 | -0.09 | -1.06% | 8.46 | 8.72 | 8.35 |
| Mar 24, 2025 | 8.64 | 0.15 | 1.77% | 8.49 | 8.99 | 8.41 |
| Mar 21, 2025 | 8.39 | 0.43 | 5.40% | 7.96 | 8.60 | 7.77 |
| Mar 20, 2025 | 7.74 | 0.38 | 5.16% | 7.36 | 7.78 | 7.35 |
| Mar 19, 2025 | 7.55 | 0.32 | 4.43% | 7.23 | 8.06 | 7.20 |
| Mar 18, 2025 | 7.33 | 0.04 | 0.55% | 7.29 | 7.52 | 6.83 |
| Mar 17, 2025 | 7.48 | 0.37 | 5.20% | 7.11 | 7.64 | 7.06 |
| Mar 14, 2025 | 7.21 | 0.01 | 0.14% | 7.20 | 7.39 | 7.03 |
| Mar 13, 2025 | 7.16 | -0.25 | -3.37% | 7.41 | 7.52 | 6.94 |
| Mar 12, 2025 | 7.61 | 0.15 | 2.01% | 7.46 | 7.85 | 7.39 |
| Mar 11, 2025 | 7.43 | 0.85 | 12.92% | 6.58 | 7.48 | 6.23 |
| Mar 10, 2025 | 6.66 | -0.47 | -6.59% | 7.13 | 7.28 | 6.43 |
| Mar 7, 2025 | 7.28 | -0.35 | -4.59% | 7.63 | 7.88 | 7.05 |
| Mar 6, 2025 | 7.74 | 0.16 | 2.11% | 7.58 | 8.22 | 7.44 |
| Mar 5, 2025 | 7.96 | 0.95 | 13.55% | 7.01 | 8.47 | 6.72 |
| Mar 4, 2025 | 8.27 | 0.57 | 7.40% | 7.70 | 8.27 | 7.61 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Adaptive Biotechnologies Corporation Company profile
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). It uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. It also focuses on developing immune-mediated therapies in oncology and other disease areas.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Adaptive Biotechnologies Corp revenues increased 57% to $154.3M. Net loss increased 42% to $207.3M. Revenues reflect Sequencing revenue segment increase of 90% to $78.9M, Development revenue segment increase of 32% to $75.4M. Higher net loss reflects Research and development - Balancing increase of 19% to $128.3M (expense), General and administrative - Balancing increase of 47% to $59.7M (expense).
| Industry: | Bio Diagnostics & Testing |
1165 Eastlake Ave E
SEATTLE
WASHINGTON 98109
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com